SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Net sales declined -28.56%  to  Rs. 730.38 million from Rs. 1022.36 millions.The company reported a drastic decline of -95.74% in the quarter ended March 2025 to Rs. 1.51  millions from Rs. 35.46 millions  .Operating profit for the quarter ended March 2025 decreased to 103.65 millions as compared to 117.49 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 730.38 1022.36 -28.56 3182.30 3685.95 -13.66 3182.30 3685.95 -13.66
Other Income 2.10 0.48 337.50 4.98 0.98 408.16 4.98 0.98 408.16
PBIDT 103.65 117.49 -11.78 363.00 174.92 107.52 363.00 174.92 107.52
Interest 40.30 39.51 2.00 149.33 139.17 7.30 149.33 139.17 7.30
PBDT 63.35 77.98 -18.76 213.67 35.75 497.68 213.67 35.75 497.68
Depreciation 46.09 38.60 19.40 163.78 146.32 11.93 163.78 146.32 11.93
PBT 17.26 39.38 -56.17 49.89 -110.57 -145.12 49.89 -110.57 -145.12
TAX 15.75 3.92 301.79 -19.35 -20.08 -3.64 -19.35 -20.08 -3.64
Deferred Tax 15.02 2.00 651.00 -20.18 -22.00 -8.27 -20.18 -22.00 -8.27
PAT 1.51 35.46 -95.74 69.24 -90.49 -176.52 69.24 -90.49 -176.52
Equity 158.28 158.28 0.00 158.28 158.28 0.00 158.28 158.28 0.00
PBIDTM(%) 14.19 11.49 23.49 11.41 4.75 140.37 11.41 4.75 140.37

Mangalam Drugs&Org. Share Price

30.56 -0.62 (-1.99%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×